Nanochon Overview
- Year Founded
-
2013
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
Series A
- (Upcoming)
- Latest Deal Amount
-
$30M
- Investors
-
22
Nanochon General Information
Description
Developer of a three-dimensional printed cartilage implant designed to replace damaged cartilage and promote new tissue growth. The company's devices replace lost or damaged cartilage and encourage new tissue growth, enabling medical practitioners to access cost-effective, on-demand devices that improve outcomes for young, active patients with knee damage.
Contact Information
Website
www.nanochon.comCorporate Office
- 7144 13th Place Northwest
- Suite 2200
- Washington, DC 20012
- United States
Corporate Office
- 7144 13th Place Northwest
- Suite 2200
- Washington, DC 20012
- United States
Nanochon Timeline
Nanochon Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 19. Later Stage VC (Series A) | $30M | Upcoming | Clinical Trials - Phase 1 | |||
| 18. Secondary Transaction - Private | 01-Jul-2026 | Completed | Clinical Trials - Phase 1 | |||
| 17. Later Stage VC | 12-May-2026 | Completed | Clinical Trials - Phase 1 | |||
| 16. Seed Round | 24-Dec-2025 | Completed | Clinical Trials - Phase 1 | |||
| 15. Accelerator/Incubator | 29-May-2024 | Completed | Clinical Trials - Phase 1 | |||
| 14. Seed Round | 06-May-2024 | Completed | Clinical Trials - Phase 1 | |||
| 13. Accelerator/Incubator | 16-Apr-2024 | Completed | Clinical Trials - Phase 1 | |||
| 12. Grant | 01-Nov-2023 | Completed | Clinical Trials - Phase 1 | |||
| 11. Seed Round | 20-Sep-2023 | $1.8M | $3.81M | Completed | Clinical Trials - Phase 1 | |
| 10. Grant | 01-Nov-2022 | $50K | $2.01M | Completed | Clinical Trials - General |
Nanochon Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed Prime-2 | ||||||||
| Seed Prime | ||||||||
| Seed Preferred | 10,841,852 | $0.000100 | $0.01 | $0.25 | $0.25 | 1x | $0.25 | 17.96% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Nanochon Comparisons
Industry
Financing
Details
Nanochon Competitors (5)
One of Nanochon’s 5 competitors is CartiHeal, a Formerly VC-backed company based in Kfar Saba, Israel.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| CartiHeal | Formerly VC-backed | Kfar Saba, Israel | ||||
| Arthrex | Private Equity-Backed | Naples, FL | ||||
| Zimmer Biomet Holdings | Corporation | Warsaw, IN | ||||
| Vericel | Formerly PE-Backed | Burlington, MA | ||||
| Anika Therapeutics | Formerly VC-backed | Bedford, MA |
Nanochon Patents
Nanochon Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026101844-A1 | Tissue implant and uses thereof | Pending | 05-Nov-2024 | ||
| WO-2025174792-A1 | Non-adhesively affixed tissue scaffolds | Pending | 13-Feb-2024 | ||
| WO-2025174829-A1 | Surgical tools for implanting a tissue scaffold | Pending | 13-Feb-2024 | ||
| EP-3829663-A1 | Implantable scaffolds and uses thereof | Active | 30-Jul-2018 | ||
| EP-3829663-A4 | Implantable scaffolds and uses thereof | Active | 30-Jul-2018 | A61L27/56 |
Nanochon Signals
Nanochon Investors (22)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Ecphora Capital | Venture Capital | Minority | ||
| TEDCO | Venture Capital | Minority | ||
| University of Virginia | University | Minority | ||
| Wilson Sonsini Goodrich & Rosati | VC-Backed Company | Minority | ||
| MedTech Innovator | Accelerator/Incubator |
Nanochon FAQs
-
When was Nanochon founded?
Nanochon was founded in 2013.
-
Where is Nanochon headquartered?
Nanochon is headquartered in Washington, DC.
-
What is the size of Nanochon?
Nanochon has 5 total employees.
-
What industry is Nanochon in?
Nanochon’s primary industry is Therapeutic Devices.
-
Is Nanochon a private or public company?
Nanochon is a Private company.
-
What is Nanochon’s current revenue?
The current revenue for Nanochon is .
-
How much funding has Nanochon raised over time?
Nanochon has raised $12.2M.
-
Who are Nanochon’s investors?
Ecphora Capital, TEDCO, University of Virginia, Wilson Sonsini Goodrich & Rosati, and MedTech Innovator are 5 of 22 investors who have invested in Nanochon.
-
Who are Nanochon’s competitors?
CartiHeal, Arthrex, Zimmer Biomet Holdings, Vericel, and Anika Therapeutics are competitors of Nanochon.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process